Behavioral Intervention

5

Review clinical trials related to Behavioral Intervention. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Expectant Moms Managing Attention-Deficit/ Hyperactivity Disorder

The goal of this study is to test a behavioral program for pregnant individuals with ADHD. This behavioral program focuses on skills for managing ADHD and related symptoms in pregnancy and postpartum. This pilot effectiveness-implementation trial aims to (1) preliminarily evaluate the MomMA behavioral intervention compared to treatment as usual (TAU) on clinical outcomes and (2) evaluate implementation outcomes, including feasibility and acceptability of clinic screening within existing OB workflows; assessment and intervention protocols; provider training/fidelity to manual; and all other study protocols from the perspective of real-world providers and participants.

Participants needed: 80
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: University of PittsburghUpdated: May 7, 2026Locations: 1
Eligibility criteria

meets full DSM-5 criteria for ADHD [+4]

substance use disorders requiring dual diagnosis treatment [+3]

Status: Not yet recruiting

Effects of Baduanjin Exercise on Improving Health in Sedentary Young and Middle-Aged Adults

The goal of this clinical trial is to learn if a 12-week Baduanjin exercise program can improve health in sedentary young and middle-aged adults. The main questions it aims to answer are: 1. Does the Baduanjin program improve participants' cardiorespiratory fitness (measured as peak oxygen uptake)? 2. Does it improve their body composition, muscle strength, balance, and flexibility? 3. Does it reduce their daily sitting time? Researchers will compare the Baduanjin training group to a health education control group to see if Baduanjin is more effective in improving these health outcomes. Participants will: 1. Be randomly assigned to one of the two groups. 2. If in the Baduanjin group, attend supervised group sessions and practice at home for 12 weeks. 3. Complete a series of assessments at the beginning, middle, and end of the study, including fitness tests, body measurements, and questionnaires.

Participants needed: 208
Trial details
Age: 18-59Biological sex: AllType: InterventionalSponsor: China-Japan Friendship HospitalUpdated: Mar 19, 2026
Eligibility criteria

Adults aged 18 to 59 years [+3]

Contraindications to cardiopulmonary exercise testing [+3]

Status: Recruiting

Reactive Driven Support for Treatment, Adherence, Resilience, and Thriving (reSTART) Clinical Trial

Men who are living with HIV and use stimulants face many challenges and barriers that may interfere with remembering to take their HIV medication. Forgetting to take HIV medication puts men living with HIV at a greater risk of becoming virally unsuppressed. Researchers are doing this study to test if a remote intervention can help participants improve remembering to take their HIV medications and reduce the HIV viral load among men living with HIV who use stimulants.

Participants needed: 270
Trial details
Age: 18-70Biological sex: MaleType: InterventionalSponsor: University of California, San FranciscoUpdated: Mar 13, 2026Locations: 1
Eligibility criteria

Prescribed antiretroviral therapy (ART) with a tenofovir-based regimen. [+4]

Have any health condition that may interfere with participation or the ability t... [+3]

Status: Recruiting

CMSL Ambulatory Sensitive Condition Nudge Study 2

The project aims to evaluate a nurse-led intervention to reduce inappropriate emergency department (ED) use among adult patients seen at Geisinger's Community Medicine Service Line (CMSL) clinics. The intervention occurs immediately following an appointment where a patient receives a diagnosis of an ambulatory sensitive condition (ASC; i.e., a condition considered to be a risk factor for near-term ED use). The evaluation will compare eligible patients with an ASC who were randomly assigned to receive follow-up outreach (patient portal message and/or call) from a nurse (who was automatically prompted via the Epic electronic health record system to initiate outreach) with those who were randomly assigned to receive standard care. Analyses will be intent-to-treat. The primary outcome is ED use in the week (i.e., 7 days) following the appointment. We ran an earlier version of this intervention (NCT06798389). The current study is modified based on results and clinical guidance. Specifically, more conditions will be included as qualifying ASCs for enrollment. Patients under 30 will be excluded. And rather than calling all patients as in the original study, patient portal users may be contacted via the portal instead of or in addition to a phone call. Finally, in the first study, the intervention was differentially effective by age group (\<45, 45-64, 65+). Our primary analysis will be conducted separately by age group, though we will also conduct an analysis combining across age groups. We will run the study until we reach at least 4,330 patients in each of the following age groups: patients aged 30-45, patients aged 45-64, patients aged 65+. Therefore, our estimated sample size is at least 4,330x3 = 12,990. We may be required to do an interim data pull and/or stop the study early at the direction of clinical or operational leaders.

Participants needed: 12,990
Trial details
Age: 30+Biological sex: AllType: InterventionalSponsor: Geisinger ClinicUpdated: Feb 11, 2026Locations: 1
Eligibility criteria

Age 30 years + [+1]

Status: Not yet recruiting

A TTM-based Smoking Cessation Intervention in Helping Expectant Fathers to Quit Smoking and Maintain Abstinence

This study aims to evaluate the effectiveness of the video-based health education in smoking cessation among expectant fathers by using two-arm randomized clinical trial to motivate this subgroup attempt to quit, quit smoking and maintain abstinence in the long term.

Participants needed: 1,346
Trial details
Age: 18+Biological sex: MaleType: InterventionalSponsor: Sun Yat-sen UniversityUpdated: Nov 6, 2024
Eligibility criteria

male adult [+3]

be or was participated in other smoking cessation program in the past year [+3]